Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer

被引：0
|
作者：
Qilai Long
Ai-Hong Ma
Hongyong Zhang
Zhixiu Cao
Roger Xia
Tzu-Yin Lin
Guru P. Sonpavde
Ralph de Vere White
Jianming Guo
Chong-Xian Pan
机构：
[1] University of California Davis,Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine
[2] Fudan University,Department of Urology, Zhongshan Hospital
[3] University of California Davis,Department of Biochemistry and Molecular Medicine, School of Medicine
[4] Wuhan University,Department of Urology, Renmin Hospital
[5] Davis Senior High School,Lank Center for Genitourinary Oncology
[6] Dana-Farber Cancer Institute,Department of Urology
[7] University of California Davis Cancer Center,Medicine
[8] VA Northern California Health Care System,undefined
[9] Harvard Medical School,undefined
来源：
Cancer Immunology, Immunotherapy | 2020年 / 69卷
关键词：
CDK4/6; Targeted therapy; Chemotherapy; Immunotherapy; Bladder cancer; Patient-derived xenograft;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2305 / 2317
页数：12
相关论文
共 50 条
  • [1] Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
    Long, Qilai
    Ma, Ai-Hong
    Zhang, Hongyong
    Cao, Zhixiu
    Xia, Roger
    Lin, Tzu-Yin
    Sonpavde, Guru P.
    White, Ralph de Vere
    Guo, Jianming
    Pan, Chong-Xian
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (11) : 2305 - 2317
  • [2] Cyclin-dependent kinase inhibitors for the treatment of lung cancer
    Qin, Angel
    Reddy, Haritha G.
    Weinberg, Frank D.
    Kalemkerian, Gregory P.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (08) : 941 - 952
  • [3] INHIBITORS OF CYCLIN-DEPENDENT KINASE AND CANCER
    BIGGS, JR
    KRAFT, AS
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1995, 73 (10): : 509 - 514
  • [4] PRECLINICAL AND CLINICAL DEVELOPMENT OF CYCLIN-DEPENDENT KINASE AND CHECKPOINT KINASE INHIBITORS
    Shapiro, G. I.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 27 - 27
  • [5] Cyclin-dependent kinase inhibitors for treating cancer
    Toogood, PL
    [J]. MEDICINAL RESEARCH REVIEWS, 2001, 21 (06) : 487 - 498
  • [6] Cyclin-dependent kinase inhibitors and human cancer
    Kamb, A
    [J]. CYCLIN DEPENDENT KINASE (CDK) INHIBITORS, 1998, 227 : 139 - 148
  • [7] Combination of Cyclin-Dependent Kinase 4 Inhibitors and Androgen Receptor Inhibitors as Cancer Therapy
    Abdel-Magid, Ahmed F.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (09): : 1408 - 1410
  • [8] Cyclin-dependent kinase inhibitors
    Westwell, A
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (09) : 491 - 491
  • [9] Cyclin-dependent kinase inhibitors
    Dai, Y
    Grant, S
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) : 362 - 370
  • [10] Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
    Thoma, Oana-Maria
    Neurath, Markus F.
    Waldner, Maximilian J.
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
12345